A Multi-center Randomized Clinical Trial About Using LMA or ETI in Elderly Patients

NCT02240901 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2900

Last updated 2020-10-29

No results posted yet for this study

Summary

Perioperative airway management is a top priority of anesthesiologists in daily work, and endotracheal intubation (ETI) is considered as the gold standard for providing safe glottic seal,effective ventilation and oxygen supplement during general anesthesia. But ETI related complications such as concomitant hemodynamic responses, damage to the oropharyngeal structures at insertion and postoperative sore throat. Laryngeal mask airway(LMA) for the anesthesia management brings new choice with invasive, lighter cardiovascular reaction and many other advantages, particularly suited to short and minimally invasive surgery. But LMA increased the risk of gastrointestinal reflux aspiration than using ETI and it may resulted in intolerance in high airway pressure, especially in elderly patients with increased lung compliance or reduced airway resistance. Furthermore, LMA could not entirely prevent the occurrence of postoperative sore throat and hoarse.

To sum up, it is necessary to carry out a multicenter clinical trial to clarify the safety of LMA in elderly patients. The investigators protocol will focus on the incidence of postoperative pulmonary complications (PPCs) when applications of LMA and ETI in elderly patients.

Conditions

  • Complications
  • Surgery

Interventions

DEVICE

Laryngeal mask airway(LMA)

Laryngeal mask airway(LMA) is used to maintain mechanical ventilation during intra-operative

DEVICE

Endotracheal intubation(ETI)

Endotracheal intubation group(ETI)is used to maintain mechanical ventilation during intra-operative

Sponsors & Collaborators

  • Fudan University

    collaborator OTHER
  • Shanghai Changzheng Hospital

    collaborator OTHER
  • Shanghai First Maternity and Infant Hospital

    collaborator OTHER
  • Huadong Hospital

    collaborator OTHER
  • West China Hospital

    collaborator OTHER
  • Shanghai Guanghua Hospital of Integrated Traditional Chinese and Western Medicine

    collaborator OTHER
  • Shanghai Jiading District Central Hospital

    collaborator OTHER
  • Shanghai Pudong New Area Gongli Hospital

    collaborator OTHER
  • Shanghai Huangpu District Central Hospital

    collaborator UNKNOWN
  • Shanghai Fengxian District Central Hospital

    collaborator OTHER
  • People's Hospital of Pudong New District

    collaborator UNKNOWN
  • First Affiliated Hospital of Wenzhou Medical University

    collaborator OTHER
  • Wuxi No. 2 People's Hospital

    collaborator OTHER
  • The First Affiliated Hospital of Xiamen University

    collaborator OTHER
  • RenJi Hospital

    lead OTHER

Principal Investigators

  • Weifeng Yu, Ph.D. · Department of Anesthesiology Renji Hospital, Shanghai Jiaotong University School of Medicine

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-08-03
Primary Completion
2020-01-23
Completion
2020-04-15

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02240901 on ClinicalTrials.gov